Drug Type Small molecule drug |
Synonyms JRD-018 |
Target |
Action inhibitors |
Mechanism BET inhibitors(Bromodomain and extra terminal domain protein inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Stem Glioma | IND Approval | China | 01 Jul 2025 | |
Myelofibrosis | IND Approval | China | 01 Jul 2025 | |
Advanced cancer | IND Approval | United States | 25 Apr 2024 |